Anticancer agent 327
Anticancer agent 327, a fluorescent Andrographolide (HY-N0191) derivative, is an NF-κB p50 inhibitor. Anticancer agent 327 covalently binds to the p50 subunit of NF-κB. Anticancer agent 327 reduces levels of multiple oncogenic p53 proteins via the autophagy/lysosome pathway. Anticancer agent 327 can be used for the research of pancreatic ductal adenocarcinoma (Ex/Em = 488/515 nm)[1].
For research use only. We do not sell to patients.
- Formula: C29H36N4O8
- Molecular Weight:568.62
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Anticancer agent 327 (Compound 4) (1-30 μM; 48 h) potently reduces viability of PANC-1 and MIA PaCa-2 PDAC cells with IC50 values of 9.94 μM and 25.30 μM, respectively[1].
Anticancer agent 327 (1-30 μM; 2-24 h) significantly reduces levels of oncogenic p53R273H in PANC-1 cells and p53R248W in MIA PaCa-2 cells in a concentration- and time-dependent manner[1].
Anticancer agent 327 (10 μM; 24 h) reduces oncogenic p53R273H protein levels in PANC-1 cells primarily through the autophagy pathway[1].
Anticancer agent 327 (1-30 μM; 24 h) potently inhibits long-term proliferation of PANC-1, MIA PaCa-2, and KPC PDAC cells, with the greatest activity against PANC-1 cells[1].
Anticancer agent 327 (1-30 μM; 10-24 h) suppresses migration of PANC-1, MIA PaCa-2, and KPC PDAC cells in a concentration-dependent manner, with the strongest activity against KPC cells[1].
Anticancer agent 327 (5-10 μM; 12 h) downregulates transcription of multiple cancer-related genes downstream of oncogenic TP53R273H, without altering TP53 mRNA levels[1].
Anticancer agent 327 (6 μM; 5 min-48 h) is rapidly taken up by PANC-1 cells, with detectable fluorescent signals within 5 min, and remains stably retained for at least 48 h[1].
Anticancer agent 327 (1-10 μM; 1 h at 25 °C) covalently binds to the NF-κB p50 subunit in vitro in a concentration-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human pancreatic ductal adenocarcinoma (PDAC) cell lines PANC-1 (p53R273H), MIA PaCa-2 (p53R248W)
-
Concentration:1 μM; 3 μM; 10 μM; 30 μM
-
Incubation Time:48 h
-
Result:Exhibited concentration-dependent cytotoxicity in both cell lines.
Had an IC50 of 9.94 μM in PANC-1 cells, with significant viability reduction at all tested concentrations.
Had an IC50 of 25.30 μM in MIA PaCa-2 cells, with significant viability reduction at 30 μM.
-
Cell Line:human PDAC PANC-1 (p53R273H) cells
-
Concentration:1 μM; 3 μM; 5 μM; 10 μM; 20 μM
-
Incubation Time:2 h; 6 h; 12 h; 24 h
-
Result:Significantly upregulated the autophagy marker LC3-II.
Caused time-dependent and concentration-dependent reduction of p53R273H.
-
Cell Line:MIA PaCa-2 (p53R248W)
-
Concentration:3 μM; 5 μM; 10 μM; 20 μM; 30 μM
-
Incubation Time:2 h; 6 h; 12 h; 24 h
-
Result:Caused time-dependent and concentration-dependent reduction of p53R248W levels.
-
Cell Line:human PDAC cell lines PANC-1 (p53R273H), MIA PaCa-2 (p53R248W), mouse PDAC cell line KPC (p53R172H)
-
Concentration:1 μM; 3 μM; 5 μM; 10 μM; 30 μM
-
Incubation Time:24 h
-
Result:Significantly suppressed colony formation in all three cell lines in a concentration-dependent manner.
Showed the strongest effect on colony formation in PANC-1 cells.
-
Cell Line:human PDAC cell lines PANC-1 (p53R273H), MIA PaCa-2 (p53R248W), mouse PDAC cell line KPC (p53R172H)
-
Concentration:1 μM; 3 μM; 10 μM; 30 μM
-
Incubation Time:10 h; 12 h; 24 h
-
Result:Suppressed migration of PANC-1 and KPC cells in a concentration-dependent manner, with no apparent cytotoxicity during the incubation period.
Reduced migration of MIA PaCa-2 cells only at 30 μM, with cytotoxicity observed at this concentration.
Caused greater suppression of migration in KPC cells than PANC-1 cells.
-
Cell Line:human PDAC PANC-1 (p53R273H) cells
-
Concentration:5 μM; 10 μM
-
Incubation Time:12 h
-
Result:Significantly reduced mRNA levels of CCNA2, PCNA, CXCL1, CXCL2, CXCL8, TIGAR, and MYC in a concentration-dependent manner.
Did not affect TP53 mRNA levels, indicating post-transcriptional regulation of p53R273H.
Suppressed MYC expression, unlike andrographolide.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (male; 4 weeks old)[1]
-
Dosage:10 mg/kg; 20 mg/kg
-
Administration:i.p.; every 2 days; 4 total doses
-
Result:Did not affect the body weights of treated mice.
Showed no evident liver or kidney toxicity, as indicated by serum biochemical parameters and histological analyses of liver and kidney tissues.
Chemical Information
-
Molecular Weight 568.62
-
Formula C29H36N4O8
-
SMILES
CN(CC1OC[C@]([C@](CCC([C@H]2C/C=C3C(OC[C@H]/3O)=O)=C)([H])[C@@]2(C)CC4)(C)[C@@H]4O1)C5=CC=C([N+]([O-])=O)C6=NON=C56
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Anticancer agent 327
- Anticancer agent327
- Anticancer agent-327
- NF-κB
- Fluorescent Dye
- Drug Derivative
- Autophagy
- NF-κB p50 subunit
- p53R273H
- pancreatic ductal adenocarcinoma cells
- MIA PaCa-2 cells
- autophagy/lysosome pathway
- KPC PDAC cells
- p53R248W
- C57BL/6 mice
- PANC-1 cells
- oncogenic p53 proteins
- Inhibitor
- inhibitor
- inhibit